Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery system

Gene Therapy
P CorbeauF Wong-Staal

Abstract

We have previously established a stable HIV-1 packaging cell line, psi 422, which yielded high titers of an HIV-1 vector capable of efficiently transducing CD4+ cells. In order to increase the safety of this gene delivery system, we have now replaced the HIV-1 vector with an HIV-2 vector to abolish any risk of homologous recombination between the packaging cells and the vector. The HIV-2 vector was also modified by insertion of a cis-acting constitutive transport element which confers Rev independence. The supernatant of psi 422 cells stably transfected with this new vector was capable of transducing CD4+ cells with a titer of 10(4) transducing units per milliliter. This result shows that cross-packaging of HIV-2 vectors with the HIV-1 packaging cells is quite efficient. Using this new stable HIV-1/HIV-2 gene delivery system, we were able to transduce human monocyte-derived primary macrophages, which are refractory to murine retrovirus-mediated transduction. The availability of a stable HIV-based gene delivery system for macrophages, a key target cell in HIV infection; is an important advance in gene therapy for AIDS.

Citations

May 18, 2000·Reviews in Medical Virology·G PalùM Pizzato
Apr 5, 2002·The Journal of Gene Medicine·Elisabetta RavotJulianna Lisziewicz
Nov 20, 1998·Current Opinion in Biotechnology·L Naldini
Nov 20, 1998·Current Opinion in Biotechnology·P J WelchF Wong-Staal
Jun 12, 2001·Human Gene Therapy·G L Buchschacher, F Wong-Staal
Feb 8, 2003·DNA and Cell Biology·Ricardo Quinonez, Richard E Sutton
Feb 13, 2002·AIDS Patient Care and STDs·Mario R Mautino, Richard A Morgan
Oct 24, 2000·Journal of Virology·J ReiserR O Brady
Dec 1, 2001·Expert Opinion on Biological Therapy·S PandyaV Planelles
Dec 24, 2005·Enfermedades infecciosas y microbiología clínica·Rafael Delgado, Benito J Regueiro
Jan 18, 2005·The Journal of Surgical Research·Lori D ConklinRichard E Sutton
Oct 31, 2007·Journal of Immunological Methods·Hui PanIgor Kramnik
Jul 5, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marc van MaanenRichard E Sutton
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·R SchroersS Y Chen
Mar 16, 2002·Gene Therapy·G PalùF Manca
Mar 12, 1999·Journal of Virology·S M WhiteV Planelles
Oct 10, 1998·Journal of Virology·T DullL Naldini

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.